Carroll Financial Associates’s Core Laboratories CLB Stock Holding History

Carroll Financial Associates’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Sell	68 -313	-82%	-$8.16K	﹤0.01%	1538
2021 Q3	$10K	Sell	381 -23	-6%	-$700	﹤0.01%	1202
2021 Q2	$15K	Hold	404	–	–	﹤0.01%	1159
2021 Q1	$11K	Hold	404	–	–	﹤0.01%	1180
2020 Q4	$10K	Hold	404	–	–	﹤0.01%	1100
2020 Q3	$6K	Hold	404	–	–	﹤0.01%	1146
2020 Q2	$8K	Sell	404 -100	-20%	-$1.79K	﹤0.01%	1074
2020 Q1	$5K	Buy	504 +193	+62%	+$5.4K	﹤0.01%	1117
2019 Q4	$11K	Hold	311	–	–	﹤0.01%	1017
2019 Q3	$14K	Buy	311 +221	+246%	+$10.3K	﹤0.01%	906
2019 Q2	$4K	Buy	90 +68	+309%	+$3.99K	﹤0.01%	1240
2019 Q1	$1K	Buy	+22	New	+$1.48K	﹤0.01%	1287
2015 Q1	–	Sell	-100	Closed	-$10.7K	–	821
2014 Q4	$10K	Buy	+100	New	+$13.1K	0.01%	479

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Carroll Financial Associates's CLB Position: Q4 2021 in Review

Carroll Financial Associates reduced its Core Laboratories (CLB) stake by 82% in Q4 2021, selling an estimated $8.16K and leaving 68 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Carroll Financial Associates first reported a position in CLB in Q4 2014 and has held it in 13 quarters since. The position peaked at $15K in Q2 2021. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

Carroll Financial Associates held 68 shares of Core Laboratories worth $1K as of Q4 2021.
Carroll Financial Associates sold 313 Core Laboratories shares in Q4 2021, an estimated $8.16K.
Core Laboratories made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1538 holding.
Carroll Financial Associates first reported a position in Core Laboratories in Q4 2014 and has held it in 13 quarters since.
Carroll Financial Associates's Core Laboratories position peaked at $15K in Q2 2021.
174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.